Live from the NIH registry
Studies recruiting near Grand Rapids right now
Top 25 of 459 recruiting studies, sorted by proximity — each links to its official registry page
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
NK-Cell Lymphoma, NK-Cell Leukemia
EARLY/Phase 1
Interventional 40 participants sought
Helen De Vos — Grand Rapids, Michigan (0.6 mi)
· Sponsor: New York Medical College
Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs
First Episode Psychosis
Phase 4
Interventional 300 participants sought
InterAct of Michigan — Grand Rapids, Michigan (0.6 mi)
· Sponsor: Northwell Health
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
Solid Malignancies, Hematologic Malignancies
Phase 1
Interventional 190 participants sought
START Midwest — Grand Rapids, Michigan (0.6 mi)
· Sponsor: Immunome, Inc.
Multilevel Community-Centered Intervention to Reduce Pregnancy Related and Associated Morbidity and Mortality (PRAMM) Disparities
Provider Confidence, Provider Behavior
N/A
Interventional 480 participants sought
Strong Beginings — Grand Rapids, Michigan (0.6 mi)
· Sponsor: Michigan State University
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
The Cancer & Hematology Centers — Grand Rapids, Michigan (0.6 mi)
· Sponsor: Pfizer
Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants With Advanced Solid Tumors
Advanced Solid Tumors
Phase 1
Interventional 121 participants sought
START Midwest, LLC — Grand Rapids, Michigan (0.6 mi)
· Sponsor: Genmab
Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
Small Cell Lung Cancer
Phase 3
Interventional 400 participants sought
Cancer and Hematology Centers of Western Michigan — Grand Rapids, Michigan (0.6 mi)
· Sponsor: Amgen
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
Advanced or Metastatic Colorectal Cancer
Phase 1, Phase 2
Interventional 225 participants sought
Start Midwest — Grand Rapids, Michigan (0.6 mi)
· Sponsor: Janssen Research & Development, LLC
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Non-small Cell Lung Cancer, Histiocytic Neoplasm
Phase 1, Phase 2
Interventional 554 participants sought
South Texas Accelerated Research Therapeutics (START) Midwest — Grand Rapids, Michigan (0.6 mi)
· Sponsor: Institut de Recherches Internationales Servier
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Corewell Health Grand Rapids Hospitals - Butterworth Hospital — Grand Rapids, Michigan (0.6 mi)
· Sponsor: NRG Oncology
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Corewell Health Grand Rapids Hospitals - Butterworth Hospital — Grand Rapids, Michigan (0.6 mi)
· Sponsor: NRG Oncology
A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
Crohn's Disease
Phase 2
Interventional 99 participants sought
Investigational Site Number: 8400008 — Wyoming, Michigan (4.2 mi)
· Sponsor: Sanofi
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
NSCLC (Advanced Non-small Cell Lung Cancer), HNSCC
Phase 1
Interventional 170 participants sought
ALX Center 3 — Grand Rapids, Michigan (0.6 mi)
· Sponsor: ALX Oncology Inc.
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Phase 2
Interventional 100 participants sought
START Midwest — Grand Rapids, Michigan (0.6 mi)
· Sponsor: C4 Therapeutics, Inc.
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Corewell Health Grand Rapids Hospitals - Butterworth Hospital — Grand Rapids, Michigan (0.6 mi)
· Sponsor: NRG Oncology
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Phase 3
Interventional 105 participants sought
Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital — Grand Rapids, Michigan (0.6 mi)
· Sponsor: Children's Oncology Group
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Head and Neck Squamous Cell Carcinoma (HNSCC), Non-small Cell Lung Cancer (NSCLC)
Phase 1, Phase 2
Interventional 27 participants sought
START Midwest — Grand Rapids, Michigan (0.6 mi)
· Sponsor: Tanabe Pharma America, Inc.
DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy
Fuchs Endothelial Corneal Dystrophy, Fuchs
Phase 2
Interventional 28 participants sought
DTX-168-201 Study Site — Grand Rapids, Michigan (0.6 mi)
· Sponsor: Design Therapeutics, Inc.
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Grand Rapids, Michigan (0.6 mi)
· Sponsor: Daiichi Sankyo
A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors
Advanced Squamous Tumors
Phase 1
Interventional 220 participants sought
START Midwest /ID# 272505 — Grand Rapids, Michigan (0.6 mi)
· Sponsor: AbbVie
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Lung Non-Small Cell Carcinoma
Phase 3
Interventional 336 participants sought
Corewell Health Grand Rapids Hospitals - Butterworth Hospital — Grand Rapids, Michigan (0.6 mi)
· Sponsor: National Cancer Institute (NCI)
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Helen DeVos Children's Hospital at Spectrum Health — Grand Rapids, Michigan (0.6 mi)
· Sponsor: SWOG Cancer Research Network
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Corewell Health Grand Rapids Hospitals - Butterworth Hospital — Grand Rapids, Michigan (0.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma
Phase 2
Interventional 396 participants sought
Corewell Health Grand Rapids Hospitals - Butterworth Hospital — Grand Rapids, Michigan (0.6 mi)
· Sponsor: SWOG Cancer Research Network
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
Neuroendocrine Tumors Unresectable, Neuroendocrine Tumor Metastatic
Phase 1, Phase 2
Interventional 300 participants sought
BAMF Health — Grand Rapids, Michigan (0.6 mi)
· Sponsor: Perspective Therapeutics